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Background: Retinoblastoma is the most common intraocular malignancy in childhood and is respon-
sible for approximately 1% of all deaths caused by childhood cancer.
Aims/methods: Comparative genomic hybridisation was performed on 13 consecutive, histologically
confirmed retinoblastomas to analyse patterns of chromosomal changes and correlate these to clinico-
pathological variables. Six cases were hereditary and seven cases were sporadic.
Results: In 11 of the 13 tumours chromosomal abnormalities were detected, most frequently gains.
Frequent chromosomal gains concerned 6p (46%), 1q (38%), 2p, 9q (30%), 5p, 7q, 10q, 17q, and
20q (23%). Frequent losses occurred at Xq (46%), 13q14, 16q, and 4q (23%). High level copy
number gains were found at 5p15 and 6p11–12. A loss at 13q14 occurred in three cases only. Rela-
tively few events occurred in the hereditary cases (27) compared with the non-hereditary cases (70
events). The number of chromosomal aberrations in these 13 retinoblastomas showed a bimodal distri-
bution. Seven tumours showed less than four chromosomal aberrations, falling into a low level chromo-
somal instability (CIN) group, and six tumours showed at least eight aberrations, falling into a high
level CIN group. In the low level CIN group the mean age was half that seen in the high level CIN
group, there were less male patients, and there were more hereditary and bilateral cases. Microsatel-
lite instability was not detected in either of the two groups.
Conclusion: Despite the complex pattern of genetic changes in retinoblastomas, certain chromosomal
regions appear to be affected preferentially. On the basis of the number of genetic events, retinoblas-
tomas can be divided in low and a high level chromosomal instability groups, which have striking dif-
ferences in clinical presentation.
Retinoblastoma is the most common intraocular malig-nancy in childhood, being responsible for approximately1% of all deaths caused by childhood cancer and for about
5% of blindness in children. According to the “two hit”
hypothesis of Knudson,1 two complementary tumour induc-
ing genetic events are necessary for retinoblast transforma-
tion. The first genetic change can occur in a germ cell (heredi-
tary) or retinoblast (non-hereditary). It is only when the
second genetic alteration occurs in a somatic target cell (a
retinoblast), already carrying a “first hit”, that malignant
transformation will occur.
Approximately 40% of patients with retinoblastoma have
the hereditary form of the disease in which the first of two
causative retinoblastoma gene (Rb) mutations is present in
most or all cells in the body.2 Simple deletion of 13q is seen
most often, although mosaicism of 13q deletion, ring chromo-
some 13, and interchanges between chromosome 13 and other
chromosomes are also possible.3 These patients have an
85–90% risk of bilateral ocular disease, and a lifetime predis-
position to non-ocular cancers throughout the body. The trait
is transmitted in an autosomal-dominant fashion with
80–90% penetrance, giving children of parents with a heredi-
tary retinoblastoma a 45% risk of developing retinoblastoma.2
The other 60% of patients with retinoblastoma have the non-
hereditary (sporadic) form of retinoblastoma, which requires
two subsequent hits to inactivate the Rb gene in a retinoblast.
This sporadic form is unilateral, not transmittable, and does
not predispose the patient second primary tumours.4 In addi-
tion to Rb inactivation, other genetic changes have been
detected in retinoblastomas, such as isochromosomes of both
17q and 6p, extra copies of 1q, monosomy 16, and abnormali-
ties of the short arm of chromosome 1 (1p).5 6 Recurrent gains
have recently been described at 1q, 2p, and 6p, and a loss at
16q.7–9
“According to the “two hit” hypothesis of Knudson, two
complementary tumour inducing genetic events are nec-
essary for retinoblast transformation”
Comparative genomic hybridisation (CGH) is a cytogenetic
technique that allows the detection of chromosomal losses
(such as monosomies and deletions) and gains (such as triso-
mies and gene amplifications) in all tumour chromosomes in
a single experiment, using only a small amount of tumour
material, and without the need for cell culturing.10 The onset
of genomic instability is a key step in carcinogenesis, and in
colorectal cancer—for example, two major types of genomic
instability have been proposed.11 Genomic instability at the
chromosomal level gives rise to frank aneuploidy. Alterna-
tively, genomic instability can occur at the DNA level—for
example, when mismatch repair fails—causing frequent
mutations (mutator phenotype), which can be demonstrated
as microsatellite instability. In our present study, chromo-
somal instability in terms of chromosomal gains and losses
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was investigated by CGH in a series of 13 retinoblastomas. In
addition, genomic instability at the DNA level was studied by
microsatellite instability analysis.
MATERIAL AND METHODS
Patient data
We studied 13 histologically confirmed consecutive retinoblas-
tomas from 13 patients. Table 1 shows the clinical data of these
patients. There were five male and eight female patients, with
a mean age of 14.2 months (range, 0–45) at date of
enucleation. Six patients had a hereditary form of retinoblast-
oma and seven patients had a non-hereditary form. In eight
patients, retinoblastoma occurred unilaterally and in five
patients bilaterally. In patients with a bilateral tumour, only
one tumour was studied. After enucleation, biopsies of the
tumour were stored at −70°C. All 13 ocular specimens were
studied histologically. According to the original histological
reports, nine tumours were undifferentiated, whereas four
tumours showed some degree of differentiation, as assessed by
the presence of Flexner-Wintersteiner rosettes; in two
tumours, superficial tumour infiltration in the optic nerve was
present, until the level of the lamina cribrosa. None of the
cases showed invasion of the choroidea.
Tissue
Normal DNA for CGH was obtained from peripheral blood
lymphocytes of a healthy female donor, and tumour DNA was
extracted from 20 sections (10 µm) of frozen biopsy speci-
mens, using the Qiagen DNA isolation kit, according to the
manufacturer’s recommendations.
Comparative genomic hybridisation
CGH was performed as described previously.12 In brief, normal
metaphase spreads were obtained by culturing lymphocytes
from a healthy female donor, according to standard proce-
dures.
Tumour DNA was labelled with biotin-16-dUTP (Roche/
Boehringer, Mannheim, Germany) and the reference DNA
with digoxigenin-11-dUTP (Roche/Boehringer) by nick trans-
lation. The concentration of DNAse I was adjusted so that the
length of the labelled DNA fragments was 0.5–1.5 kb.
The hybridisation of the DNA on metaphase spreads was
performed as follows: 300 ng of biotin labelled tumour and
300 ng of digoxigenin labelled normal DNA, together with
40 µg unlabelled Cot-1 DNA (Gibco BRL, Breda, the Nether-
lands), were ethanol precipitated and the pellet was dissolved
in 6 µl 50% formamide, 10% dextrane sulfate in 2× saline
sodium citrate (SSC; 0.3M sodium chloride, 0.03M sodium
citrate, pH 7.0). This probe mixture was denatured at 80°C for
10 minutes. Normal metaphase slides were denatured at 72°C
for six minutes in a coplin jar containing 70% formamide in 2×
SSC, pH 7.0. The probe mixture was mounted on to the slides,
sealed with a cover slip, and hybridised for three days in a
humid incubator at 40°C.
Table 1 Clinical data of the 13 patients with retinoblastoma
No.
Age at
diagnosis Sex H/N Site
Grade of
differentiation
Ingrowth in
optic nerve Follow up
1 16 months M N Uni UD – NED 8 years
2 Birth M N Uni UD – Died after 2 months
3 6 months F H Bi WD – NED, 8 years
4 1 month M H Bi WD – Secondary pinealoblastoma, died
41 months
5 45 months F N Uni WD – NED, 7 years
6 4 months M H Bi UD – NED, 3 years
7 6 months F N Uni UD + NED, 3 years
8 12 months M N Uni UD + NED, 3 years
9 5 days F H Bi WD – NED, 2 years
10 38 months F N Uni UD – NED, 2 years
11 23 months F N Uni UD – NED, 1 year
12 25 months F H Uni UD – NED, 1 year
13 9 months F H Bi UD – NED, 1 year
Bi, bilateral; F, female; H, hereditary; M, male; N, non-hereditary; NED, no evidence of disease; UD,
undifferentiated; Uni, unilateral; WD, well differentiated.
Table 2 Chromosomal aberrations detected by comparative genomic hybridisation
in 13 retinoblastomas
No.
Hereditary (H) or
non-hereditary (N) CGH gains CGH losses
1 N 9q, Xp, Xq –
2 N 4q, 5p, 5q, 6q, 8q, 9p, 10q, 11p,
12q, 13q, 14q, 18q
–
3 H 6p Xq
4 H – –
5 N 1q, 4p, 5p, 6p, 6q, 17q, 18p, 18q,
21q (5p15 amplif)
8q, 10q, 13q, 15q, 16p, 16q, 18q, Xp,
Xq
6 H 8q Xq
7 N 6p (6p11–12 amplif) 13q
8 N 2p, 8p, 10q –
9 H – –
10 N 1q, 6p, 7p, 7q, 9q, 10p, 10q, 11p,
11q, 13q, 17q, 20q, 22q
3p, 3q, 4p, 4q, 8p, 8q, 14q, Xp, Xq
11 N 1q, 2p, 6p, 7q, 9q 4q, 10q, 16q, Xq
12 H 1q, 2p, 5p, 6p, 11q, 20q 4q, 13q, 16p, 16q, Xq
13 H 1p, 1q, 2p, 7q, 9q, 12q, 17q, 20q 17p
The figures in bold are high level copy number gains.
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The slides were washed for five minutes in 2× SSC at room
temperature, three times for five minutes in 0.1× SSC at 45°C,
and once for five minutes in 0.05% Tween 20 in TN (100mM
Tris/HCl, pH 7.6, 150mM sodium chloride). The slides were
then pre-incubated for 10 minutes at 40°C in blocking solution
(0.5% blocking reagent (Roche/Boehringer) in TN), followed
by a 60 minute incubation at 40°C with 12.5 µg/ml fluorescein
isothiocyanate (FITC) conjugated avidin (Sigma Aldrich, Zwi-
jndrecht, Netherlands) and 4 µg/ml tetramethyl rhodamine
isothiocyanate (TRITC) conjugated sheep antidigoxigenin
(Roche/Boehringer) in blocking solution. The slides were
washed three times for five minutes at room temperature in
0.05% Tween 20 in TN and dried in an ethanol series. Finally,
the slides are mounted with 20 µl antifade solution (Vectash-
ield; Vector Laboratories, Burlingame, California, USA) con-
taining 0.35 µg/µl DAPI.
The slides were analysed on a Leica DM-RA microscope
(Leica, Cambridge, UK) equipped with filter sets for DAPI,
FITC, and TRITC, using a ×100 objective. The images were cap-
tured with a monochrome CCD camera (Cohu 4913; Cohu Inc,
San Diego, California, USA) and processed by Cytovision CGH
software (Cyto Vision 3.5; Applied Imaging, Newcastle upon
Tyne, UK). The average green to red fluorescence ratios of
chromosomes of 10 to 15 well selected metaphases were plot-
ted along ideograms of the corresponding chromosomes,
together with the 95% confidence interval. Deviations from
normal were interpreted as gains and losses when the 95%
confidence interval did not contain 1.0. Small, distinct loci
showing a green to red fluorescence ratio greater than 1.5 were
regarded as high level amplifications. Chromosomes 19, 1p32-
ter, and 16p were excluded from the analysis because the
presence of repetitive sequences may interfere with a reliable
interpretation of the green to red fluorescence ratio in these
areas.
Microsatellite instability
Microsatellite instability was studied using the Roche HNPCC
microsatellite instability test. The reference panel markers
used were: BAT25, BAT26, D2S123, D5S346, and D17S250.
Normal (non-tumour) tissue from the enucleated eye of
each patient was used as a control.
Statistics
The Mann-Whitney U test was used for comparing means of
continuous variables between the two groups. For significance
of differences in the distribution of categorical variables, cross
tables were analysed with the two sided Fisher exact test; p
values < 0.05 were considered significant.
RESULTS
CGH analysis revealed chromosomal abnormalities in 11 of 13
cases. Table 2 lists the results for individual retinoblastomas
and fig 1 shows an overview of the affected regions. As shown
in fig 2, the number of chromosomal aberrations showed a
bimodal frequency distribution. In one group of patients with
a low level of chromosomal instability (CIN), tumours had
only none to three events, whereas in the group with a high
level of chromosomal instability there were eight or more
events. Table 3 summarises the details on these two groups.
The mean age in the low level CIN group is about half that of
the high level group (p = 0.07). In the low level CIN group,
Table 3 Comparison of comparative genomic
hybridisation results and clinicopathological variables
between retinoblastomas with low level and those with
high level chromosomal instability (CIN)
Low level CIN
(<6 events)
n=7
High level CIN
(>6 events)
n=6 p Value
Events (mean) 1.7 14.2 0.02
Gains (mean) 1.3 9.5 0.03
Losses (mean) 0.4 4.7 0.02
Age (mean, in months) 10.1 23.3 NS
Male to female ratio 1.3:1 5:1 NS
Hereditary (%) 57 33 NS
Bilateral (%) 57 17 NS
Undifferentiated (%) 57 83 NS
Death of disease (%) 14 17 NS
NS, not significant.
Figure 1 Overview of affected
chromosomal regions in the 13
retinoblastomas as detected by
comparative genomic hybridisation.
Lines left of each chromosome
represent losses, and lines on the
right represent gains. Thick solid lines
represent high level copy number
gains (amplifications).
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there were fewer male patients, and more hereditary and
bilateral cases. Because of the small number of case, these dif-
ferences were not significant.
Overall, gains were seen more frequently than losses, on
average 5.0 and 2.4 for each case, respectively. A mean of 7.5
events (range, 0–14) was found. The most frequent losses were
at Xq (46%), 13q14, 16q, and 4q (23%). Frequent gains were
found at 6p (46%), 1q (38%), 2p and 9q (30%), 5p, 7q, 10q, 17q,
and 20q (23%). High level copy number gains were detected in
two cases, at chromosome regions 5p15 and 6p11–12, respec-
tively.
A 13q loss, very localised at band 13q14 only, occurred in
only three cases (one of which was hereditary whereas the
other two were non-hereditary) and a 13q gain was seen in
two cases (both of them being non-hereditary).
In the six hereditary cases, 27 events occurred (mean,
4.5)—19 gains and eight losses—whereas in the seven
non-hereditary cases there were 70 events (mean, 10)—47
gains and 23 losses. However, these differences also were not
significant. Four patients had a well differentiated tumour. In
two of these tumours no events occurred. In one patient, only
a gain at 6p and a loss at Xq were found. In the fourth patient,
nine gains and nine losses were detected. This means that
most patients with a well differentiated tumour belonged to
the low level CIN group.
Five (hereditary) patients had a bilateral tumour. In two of
these tumours no events were found, in two other patients,
two events each (gains at 6p or 8q, losses at Xq) were found,
and in the fifth patient 10 gains and one loss were found. Most
patients with a hereditary, bilateral retinoblastoma belonged
to the low level CIN group.
Overall, two patients (cases 2 and 4) died of disease during
an average follow up period of 39.3 months (range, 2–96). The
first patient still had residual disease after surgery with
outgrowth of the tumour at the next visit. Palliative treatment
was instituted on request of the parents. The tumour of this
patient had 12 gains. The other patient developed a secondary
tumour (a pinealoblastoma) of which he died 41 months after
detection of the retinoblastoma. The retinoblastoma of this
patient showed no detectable chromosomal aberrations.
In none of the 13 retinoblastoma patients was microsatellite
instability detected.
DISCUSSION
CGH is the method of choice for analysing chromosomal
instability. It may serve as a first line analysis in tumour
genetics, pointing to regions of interest for further, more
detailed, molecular genetic studies, such as fluorescence in
situ hybridisation, loss of heterozygosity analysis, and DNA
sequencing. It is a relatively fast screening technique that can
point at specific chromosomal regions that might play a role in
the pathogenesis or progression of tumours.12 Until now, few
CGH studies have been reported in retinoblastoma.7–9
With respect to specific chromosomal changes, Mairal and
colleagues7 reported over representation of 1q, 2p, and 6p, and
loss of 9p, 13q14, and 16q. In addition, they detected high level
copy number gains at 2p23–25 and 1q21. Similar findings have
been reported by others.4 7–9 Our results are partly in
agreement with this (for example, 1q, 2p, 6p, 13q14), although
there are also differences (for example, gain at 9q, loss at Xq).
In our study, we found a loss at 13q14 (the site of the Rb
gene) in only three patients; two of these patients had a non-
hereditary retinoblastoma and one a hereditary retinoblast-
oma. Two other patients had a gain at 13q14. The finding of a
normal chromosome 13 in patients with retinoblastoma has
been reported before. In these patients, changes in other chro-
mosomes such as chromosome 1 and 17 have been
reported.6 13
Although in absolute numbers our series was only small (13
patients), given the low incidence of retinoblastoma, it was
still a valuable study. According to the number of chromo-
somal aberrations found, two groups could be distinguished,
one group with low level CIN and one group with high level
CIN. Even though the groups are small, some striking
differences were seen. Patients in the low level CIN group were
younger, there were more male patients, and more hereditary,
bilateral tumours were seen than in the high level CIN group.
Similar findings were reported recently by Herzog et al,8 who
found, in a study of unilateral retinoblastomas, that older
children (36.2–84.1 months) had a higher level of CIN than
younger children (2.0–9.8 months).
“In our study, we found a loss at 13q14 (the site of the
Rb gene) in only three patients”
Cytogenetic analysis of retinoblastomas with regard to
chromosome 6 has been reported by Cano et al.14. In 14 of the
34 tumours studied, additional copies of 6p were found. The
nature of these 6p imbalances were isochromosome 6p, trans-
locations of 6p to other chromosomes, tetrasomy 6, and addi-
tional derived 6q. It was suggested that the presence of addi-
tional copies of 6p is associated with an undifferentiated
histology and invasion of the optic nerve, which are both indi-
cators of a bad prognosis. In our study, six of the 13 patients
had a gain at 6p. Four of these patients had an undifferenti-
ated tumour and in only one case there was (superficial)
Figure 2 The number of chromosomal aberrations detected by
comparative genomic hybridisation in 13 retinoblastomas shows a
bimodal distribution, with seven cases showing low level
chromosomal instability (CIN) and six cases showing high level CIN.
Figure 3 Green to red fluorescence ratios of chromosomes 6 and
13 (both measured as an average over 22 hybridised chromosomes)
of retinoblastoma case number seven. These two chromosomes
carried the only abnormalities present in this tumour, showing a gain
of the complete short arm of chromosome 6, including a small region
with amplification on bands 6p11–12, and a small loss on
13q14–21, which is the site of the retinoblastoma locus.
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tumour infiltration in the optic nerve (patient 7).
Nevertheless, all six patients are alive without evidence of dis-
ease.
Six of the 13 tumours in our present study had a gain at
6p21.3–22, which is in line with the observations of Chen et
al.9 In addition, we found high level amplification at 6p12.3 in
one tumour (fig 3), suggesting an important gene is present at
this site. The gain at 2p could correspond to the NMYC gene,
which has been reported to be of prognostic relevance in neu-
roblastoma, another embryonic neuroectodermal tumour.15 16
However, in our study (and in other studies) no relation could
be found between the over representation of 2p and prognosis
in retinoblastoma.
The bimodal distribution of chromosomal changes in
retinoblastomas is an intriguing observation, which could
point to fundamentally different mechanisms of genomic
instability in the high and low level CIN tumours. In colorectal
cancer a similar situation occurs, where microsatellite
unstable tumours with a failing DNA mismatch repair system
show only minor chromosomal changes in contrast to micros-
atellite stable tumours, which are often frankly aneuploid.
However, in our present study, microsatellite instability was
detected in none of the retinoblastomas, either low or high
level CIN, indicating that other mechanisms may confer
genomic instability in low level CIN retinoblastomas. In addi-
tion, CIN status (either low or high level) was associated with
several clinicopathological variables. Low level CIN retinoblas-
tomas were more frequently hereditary and bilateral, whereas
high level CIN tumours occurred more frequently in older,
male patients, and were more often undifferentiated.
These observations support the hypothesis that two
biologically different categories of retinoblastomas exist,
which seem to have a different clinical behaviour.
ACKNOWLEDGEMENT
We thank R Broekhuizen and C Postma for their technical assistance.
. . . . . . . . . . . . . . . . . . . . .
Authors’ affiliations
J E van der Wal, M A J A Hermsen, G A Meijer, P van der Valk,
Department of Pathology, VU University Medical Centre, PO Box 7057,
1007 MB Amsterdam, The Netherlands
H J P Gille, Department of Clinical Genetics, VU University Medical
Centre
N Y N Schouten-van Meeteren, A C Moll, S M Imhof, Departments of
Paediatrics and Ophthalmology, VU University Medical Centre
J P A Baak, Department of Pathology, SIR Hospital, Stavanger, Norway
REFERENCES
1 Knudson AG. Mutation and cancer: statistical study of retinoblastoma.
Proc Natl Acad Sci U S A 1971;68:820–3.
2 Harbour JW. Overview of RB gene mutations in patients with
retinoblastoma. Implications for clinical genetic screening.
Ophthalmology 1998;105:1442–7.
3 Mao W, Lin X, Ma Q, et al. Lymphocyte chromosome survey in 80
patients with retinoblastoma. Eye Science 1989;5:7–13.
4 Potluri VR, Helson L, Ellsworth RM, et al. Chromosomal abnormalities in
human retinoblastoma. A review. Cancer 1986;58:663–71.
5 Chaum E, Ellsworth RM, Abramson DH, et al. Cytogenetic analysis of
retinoblastoma: evidence for multifocal origin and in vivo gene
amplification. Cytogenet Cell Genet 1984;38:82–91.
6 Gardner HA, Gallie BL, Knight LA, et al. Multiple karyotypic changes in
retinoblastoma tumor cells: normal chromosome no. 13 in most tumors.
Cancer Genet Cytogenet 1982;6:201–11.
7 Mairal A, Pinglier E, Gilbert E, et al. Detection of chromosome
imbalances in retinoblastoma by karyotypic analysis coupled to
comparative genomic hybridization. Genes Chromosomes Cancer
2000;28:370–9.
8 Herzog S, Lohmann DR, Buiting K, et al. Marked differences in unilateral
isolated retinoblastomas from young and older children studied by
comparative genomic hybridization. Hum Genet 2001;108:98–104
9 Chen D, Gallie BL, Squire JA. Minimal regions of chromosomal
imbalance in retinoblastoma detected by comparative genomic
hybridization. Cancer Genet Cytogenet 2001;129:57–63.
10 Hermsen MAJA, Meijer GA, Baak JPA, et al. Comparative genomic
hybridisation: a new tool in cancer pathology. Hum Pathol
1996;27:342–9.
11 Cahill DP, Kinzler KW, Vogelstein B, et al. Genetic instability and
darwinian selection in tumours. Trends Cell Biol 1999;9:57–60.
12 Weiss MM, Hermsen MAJA, Meijer GA, et al. Comparative genomic
hybridisation. Mol Pathol 1999;52:243–51.
13 Squire J, Gallie BL, Phillips RA. A detailed analysis of chromosomal
changes in heritable and non-heritable retinoblastoma. Hum Genet
1985;70:291–301.
14 Cano J, Oliveros O, Yunis E. Phenotype variants, malignancy, and
additional copies of 6p in retinoblastoma. Cancer Genet Cytogenet
1994;76:112–15.
15 Doz F, Peter M, Schleiermacher G, et al. N-MYC amplification, loss of
heterozygosity on the short arm of chromosome 1 and DNA ploidy in
retinoblastoma. Eur J Cancer 1996;32:645–9.
16 Tsuda H, Shimosato Y, Upton MP, et al. Retrospective study on
amplification of N-myc and c-myc genes in pediatric solid tumors and its
association with prognosis and tumor differentiation. Lab Invest
1988;59:321–7.
Take home messages
• The pattern of genetic changes in retinoblastomas is
extremely complex
• Nonetheless, certain chromosomal regions appear to be
affected preferentially
• Relatively few events occurred in the hereditary cases (27)
compared with the non-hereditary cases (70 events)
• On the basis of the number of genetic events, retinoblasto-
mas can be divided in low and a high level chromosomal
instability groups, which have striking differences in clinical
presentation
• In the low level CIN group the mean age was half that seen
in the high level CIN group, there were less male patients,
and there were more hereditary and bilateral cases
• Microsatellite instability was not detected in either of the
two groups
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